Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Papathanasiou

Showing results (51-60 of 77) with videos related to

Pageof 8
Sort By:
Annals of Clinical and Translational Neurology|April 30, 2022
Corneal confocal microscopy to detect early immune-mediated small nerve fibre loss in AL amyloidosisAndreas Thimm, Alexander Carpinteiro, Sara Oubari, et al.
BMC Neurology|December 10, 2022
A novel TTR mutation (p.Ala65Val) underlying late-onset hereditary transthyretin (ATTRv) amyloidosis with mixed cardiac and neuropathic phenotype: a case reportAndreas Thimm, Sara Oubari, Julia Hoffmann, et al.
Journal of Neurology|April 4, 2023
Corneal confocal microscopy identifies corneal nerve loss and increased Langerhans cells in presymptomatic carriers and patients with hereditary transthyretin amyloidosisAndreas Thimm, Alexander Carpinteiro, Sara Oubari, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|May 13, 2022
Quantitative <sup>99m</sup>Tc-DPD-SPECT/CT assessment of cardiac amyloidosisLukas Kessler, Pedro Fragoso Costa, David Kersting, et al.
The International Journal of Artificial Organs|October 22, 2021
Rescue extracorporeal life support as a bridge to durable left ventricular assist deviceAlina Zubarevich, Konstantin Zhigalov, Marcin Szczechowicz, et al.
Annals of Hematology|March 22, 2025
Gain or amplification of 1q21 in systemic light chain amyloidosis is associated with advanced Mayo stage, plasma cell disease and worse overall survivalSara Oubari, Maria Papathanasiou, Lars Michel, et al.
Neurological Research and Practice|December 16, 2020
Prevalence of hereditary transthyretin amyloid polyneuropathy in idiopathic progressive neuropathy in conurban areasAndreas Thimm, Saskia Bolz, Michael Fleischer, et al.
Haematologica|July 13, 2023
Daratumumab in first-line treatment of patients with light chain amyloidosis and Mayo stage IIIb improves treatment response and overall survivalSara Oubari, Ute Hegenbart, Renate Schoder, et al.
Transplantation and Cellular Therapy|July 28, 2021
Survival Advantage of Treosulfan Plus Fludarabine Before Allogeneic Hematopoietic Cell Transplantation for Older or Comorbid Patients With Myeloid MalignanciesIoanna Sakellari, Eleni Gavriilaki, Despina Mallouri, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|October 7, 2020
<sup>18</sup>F-flutemetamol positron emission tomography in cardiac amyloidosisMaria Papathanasiou, Lukas Kessler, Alexander Carpinteiro, et al.
Pageof 8

Showing results (51-60 of 77) with videos related to

Sort By:
Pageof 8
Annals of Clinical and Translational Neurology|April 30, 2022
Corneal confocal microscopy to detect early immune-mediated small nerve fibre loss in AL amyloidosisAndreas Thimm, Alexander Carpinteiro, Sara Oubari, et al.
BMC Neurology|December 10, 2022
A novel TTR mutation (p.Ala65Val) underlying late-onset hereditary transthyretin (ATTRv) amyloidosis with mixed cardiac and neuropathic phenotype: a case reportAndreas Thimm, Sara Oubari, Julia Hoffmann, et al.
Journal of Neurology|April 4, 2023
Corneal confocal microscopy identifies corneal nerve loss and increased Langerhans cells in presymptomatic carriers and patients with hereditary transthyretin amyloidosisAndreas Thimm, Alexander Carpinteiro, Sara Oubari, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|May 13, 2022
Quantitative <sup>99m</sup>Tc-DPD-SPECT/CT assessment of cardiac amyloidosisLukas Kessler, Pedro Fragoso Costa, David Kersting, et al.
The International Journal of Artificial Organs|October 22, 2021
Rescue extracorporeal life support as a bridge to durable left ventricular assist deviceAlina Zubarevich, Konstantin Zhigalov, Marcin Szczechowicz, et al.
Annals of Hematology|March 22, 2025
Gain or amplification of 1q21 in systemic light chain amyloidosis is associated with advanced Mayo stage, plasma cell disease and worse overall survivalSara Oubari, Maria Papathanasiou, Lars Michel, et al.
Neurological Research and Practice|December 16, 2020
Prevalence of hereditary transthyretin amyloid polyneuropathy in idiopathic progressive neuropathy in conurban areasAndreas Thimm, Saskia Bolz, Michael Fleischer, et al.
Haematologica|July 13, 2023
Daratumumab in first-line treatment of patients with light chain amyloidosis and Mayo stage IIIb improves treatment response and overall survivalSara Oubari, Ute Hegenbart, Renate Schoder, et al.
Transplantation and Cellular Therapy|July 28, 2021
Survival Advantage of Treosulfan Plus Fludarabine Before Allogeneic Hematopoietic Cell Transplantation for Older or Comorbid Patients With Myeloid MalignanciesIoanna Sakellari, Eleni Gavriilaki, Despina Mallouri, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|October 7, 2020
<sup>18</sup>F-flutemetamol positron emission tomography in cardiac amyloidosisMaria Papathanasiou, Lukas Kessler, Alexander Carpinteiro, et al.
Pageof 8